U.S. Hotel and Resort REITs Stock News

In early March 2026, Genevant Sciences and Arbutus Biopharma reached a global settlement with Moderna over alleged unauthorized use of LNP delivery technology in its COVID-19 vaccines, with Moderna agreeing to pay US$950 million upfront in July 2026 and up to an additional US$1.30 billion depending on a future appellate ruling, while also receiving a global non-exclusive license for infectious disease applications. Around the same time, Moderna reported completion of a key Phase 1...

Jack Henry & Associates (JKHY) is back in focus after its Financial Crimes Defender platform was added to the Independent Community Bankers of America Preferred Service Provider program, highlighting its role in fraud prevention for community banks. See our latest analysis for Jack Henry & Associates. At a latest share price of $168.77, Jack Henry & Associates has seen a 7.71% 1 month share price return but a 10.06% 3 month share price decline. Its 5 year total shareholder return of 21.27%...

Interest in Polaris (PII) has picked up after its addition to the Russell 1000 ETF, along with plans to sell its Indian motorcycle brand to Carolwood and fresh coverage from Wells Fargo. See our latest analysis for Polaris. Despite the latest headlines, momentum in Polaris stock has cooled, with a 30-day share price return of 23.38% and a year to date share price return of 24.14%, even as the 1-year total shareholder return stands at 25.31%. Recent attention around its Russell 1000 inclusion,...

In recent days, Sunrun reported softer expectations for near-term earnings as analysts cut forecasts and voiced concern about slower solar origination and capacity deployment, even while revenue is still expected to grow. At the same time, Sunrun remains a major force in U.S. residential battery storage, controlling roughly half of 2025 installations and about 44% of national residential storage capacity, highlighting a tension between operational leadership and financial strain. Now we’ll...

Dianthus Therapeutics recently reported an early GO decision in its Phase 3 CAPTIVATE trial of claseprubart for CIDP, after achieving 20 confirmed responders ahead of the planned interim analysis and confirming a favorable safety profile through independent DSMB review. On the heels of these clinical results, the company completed a large follow-on public equity offering of common stock and pre-funded warrants, raising roughly US$719,000,000 to support ongoing trials, commercial readiness,...

What Recent Returns Say About BorgWarner BorgWarner (BWA) has drawn investor attention after a mixed run in its share price, with a recent month decline contrasting with gains over the past 3 months, year to date, and the past year. That backdrop, alongside annual revenue of about US$14.3b and net income of US$277 million, sets the stage for a closer look at how the auto technology supplier’s current valuation compares with its recent performance. See our latest analysis for BorgWarner. At...

In March 2026, Agios Pharmaceuticals announced that the Emirates Drug Establishment approved PYRUKYND (mitapivat) as the only authorized treatment in the UAE for adult patients with both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, expanding its reach in the Gulf region via its NewBridge Pharmaceuticals partnership. This approval deepens Agios’s footprint in rare hematologic diseases across the Gulf Cooperation Council, reinforcing the importance of...

Event context and recent share performance Sonic Automotive (SAH) has drawn investor attention after a period of mixed share performance, with the stock down about 1% over the past week and roughly 9% over the past 3 months. See our latest analysis for Sonic Automotive. At a share price of $59.89, Sonic Automotive’s recent 1 day and 90 day share price declines of 1.32% and 8.8% contrast with a 1 year total shareholder return of 4.01%. This suggests that short term momentum has cooled while...

Cboe Global Markets, Inc. has announced plans to launch the Cboe IBIT Volatility Index and a new prediction markets framework, extending its VIX methodology into bitcoin and introducing three-outcome, fixed-return contracts initially tied to Mini S&P 500 Index prediction markets. By pairing a bitcoin volatility gauge with an options-style prediction market that allows partial payouts, Cboe is seeking to broaden access to outcome-based trading while aligning it with established exchange...

In March 2026, Guidewire Software reported quarterly results showing revenue of US$359.1 million and net income of US$60.11 million, alongside higher full-year guidance and accelerating annual recurring revenue growth. A key client, IAG New Zealand, also migrated its on-premises ClaimCenter system to the Guidewire Cloud Platform, underscoring growing adoption of Guidewire’s cloud-based insurance solutions. Next, we’ll explore how Guidewire’s stronger guidance and accelerating cloud...

Trevi Therapeutics (TRVI) has secured FDA alignment on its clinical plan for nalbuphine ER in IPF related chronic cough, clearing the way for two randomized, double blind, placebo controlled Phase 3 trials starting later this year. See our latest analysis for Trevi Therapeutics. That FDA alignment comes after a recent pullback, with a 7 day share price return showing a decline of 17.22% and a 90 day share price return showing a decline of 12.69%. However, the 1 year total shareholder return...

Coca-Cola FEMSA. de (NYSE:KOF) is back on investor radars after recent trading left the shares with a mixed return profile, including a 2.2% decline over the past day and 6.8% over the past week. See our latest analysis for Coca-Cola FEMSA. de. The recent 1-month share price return of a 13.8% decline contrasts with Coca-Cola FEMSA. de’s 90-day share price return of 3.5% and 1-year total shareholder return of 13.6%. This suggests shorter term momentum has cooled, while longer term holders have...

In February 2026, Charles Schwab reported core net new assets of US$32.50 billion and a 9% year-over-year rise in 395,000 new brokerage accounts, alongside updated revenue guidance pointing to faster first-quarter revenue growth. Together with Schwab’s finalized acquisition of Forge Global to expand access to private markets, these figures highlight how the firm is broadening its investing platform while deepening client engagement. We’ll now examine how Schwab’s stronger February asset...

American Electric Power has appointed Adrian Rodriguez as president and chief operating officer of AEP Texas, following Judith Talavera’s departure, as the subsidiary continues to support approximately 1,094,000 Texas customers and taps the bond market with a US$750 million senior notes issuance due 2036. Rodriguez’s extensive regulatory and operational background in Texas and New Mexico could be important as AEP pursues long-term load growth from data centers and industrial customers across...

Xcel Energy (XEL) has drawn fresh attention after issuing US$800,000,000 of 5.75% junior subordinated notes due 2056, a long dated financing move that sits alongside reaffirmed earnings guidance and a large investment pipeline. See our latest analysis for Xcel Energy. At a share price of US$81.91, Xcel Energy has a 90 day share price return of 8.17% and a year to date share price return of 9.68%. Its 1 year total shareholder return of 21.15% and 5 year total shareholder return of 52.37%...

NGL Energy Partners (NGL) has drawn fresh investor attention after closing a seven year US$950 million senior secured term loan and amending its asset based revolving credit facility to reshape its capital structure. See our latest analysis for NGL Energy Partners. These financing moves come after a strong run for investors, with the 1 year total shareholder return at about 140%. At the same time, the recent 1 month share price return of a 6.67% decline suggests some cooling in short term...

Why Sonos stock is drawing attention now Sonos (SONO) is back on many investors’ watchlists after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. See our latest analysis for Sonos. At a share price of $13.15, Sonos has seen a 4.5% 1 day share price decline and a 28.26% 3 month share price return, while the 1 year total shareholder return is 15.15%. This suggests that shorter term momentum is fading even...

What recent returns suggest about Chemed’s profile Chemed (CHE) has drawn attention after a month return of about 15% decline and a past 3 months return of about 7% decline, raising questions about how its current valuation lines up with its fundamentals. See our latest analysis for Chemed. At a share price of US$401.87, Chemed’s recent 30-day share price return of about a 15% decline and 1-year total shareholder return of about a 32% decline point to fading momentum after a weaker period for...

On March 9, 2026, Viper Energy withdrew a prior shelf registration for debt securities and filed a new omnibus shelf covering Class A common stock, preferred stock, warrants, and debt. This refreshed universal shelf registration increases the company’s flexibility to raise different types of capital, which may support its dividend-focused, royalty-based business model over time. We’ll now examine how this expanded capital-raising flexibility could influence Viper Energy’s existing investment...

Aeva Technologies recently presented at the Morgan Stanley Technology, Media & Telecom Conference and the 2nd Annual CG Virtual Sustainability Summit, and has since marked its fifth anniversary as a public company by ringing the Nasdaq Closing Bell. Together with expanding its next-generation perception platform into factory automation, smart infrastructure and defense, Aeva has also delivered five consecutive quarters of rising net sales, indicating building operational momentum despite...

Tenet Healthcare (THC) is back in focus after reporting fourth quarter 2025 earnings that exceeded consensus estimates, updating its 2026 outlook, and continuing an active share repurchase program. See our latest analysis for Tenet Healthcare. At a share price of $227.63, Tenet Healthcare has seen a 1-day share price return of 1.29%, a 90-day share price return of 15.36% and a 1-year total shareholder return of 85.56%. This reflects strong momentum that aligns with the recent earnings beat,...

Quarterly results put H&R Block’s AI model in focus H&R Block (HRB) is back in the spotlight after recent quarterly results highlighted revenue growth tied to a 15.6% rise in assisted tax preparation and a 22.3% gain in do it yourself software usage. For investors, the company’s combination of human expertise and AI tools, which has reportedly outperformed more AI native competitors, raises questions about how this model might support H&R Block’s business mix and long term positioning. See...

Appian (APPN) is back on investors’ radar after Q4 revenue grew 21.7% year over year, beating analyst estimates, with billings and ahead-of-consensus EBITDA guidance contrasting with a comparatively cautious full-year outlook. See our latest analysis for Appian. Despite the upbeat Q4 report, Appian’s recent trading has been choppy, with a 30-day share price return of 11.89%, a 90-day share price return of 30.65%, and a 1-year total shareholder return of a 15.21% loss. This suggests that...

Enpro (NPO) has drawn attention after its recent share moves, with the stock down about 12% over the past month but still showing a positive total return over the past 3 months. See our latest analysis for Enpro. That recent 11.7% 30 day share price decline, alongside a softer 7 day move, sits against a 10.4% 90 day share price return and a 1 year total shareholder return of 37.8%. This suggests momentum has cooled after a strong run. If Enpro’s move has you thinking about where growth and...